|
1
|
Weitz J, Koch M, Debus J, Hohler T, Galle
P and Buchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hu CE and Gan J: TRIM37 promotes
epithelial-mesenchymal transition in colorectal cancer. Mol Med
Rep. 15:1057–1062. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boutin AT, Liao WT, Wang M, Hwang SS,
Karpinets TV, Cheung H, Chu GC, Jiang S, Hu J, Chang K, et al:
Oncogenic Kras drives invasion and maintains metastases in
colorectal cancer. Genes Dev. 31:370–382. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Williams KJ, Argus JP, Zhu Y, Wilks MQ,
Marbois BN, York AG, Kidani Y, Pourzia AL, Akhavan D, Lisiero DN,
et al: An essential requirement for the SCAP/SREBP signaling axis
to protect cancer cells from lipotoxicity. Cancer Res.
73:2850–2862. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Griffiths B, Lewis CA, Bensaad K, Ros S,
Zhang Q, Ferber EC, Konisti S, Peck B, Miess H, East P, et al:
Sterol regulatory element binding protein-dependent regulation of
lipid synthesis supports cell survival and tumor growth. Cancer
Metab. 1:32013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bao J, Zhu L, Zhu Q, Su J, Liu M and Huang
W: SREBP-1 is an independent prognostic marker and promotes
invasion and migration in breast cancer. Oncol Lett. 12:2409–2416.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li W, Tai Y, Zhou J, Gu W, Bai Z, Zhou T,
Zhong Z, McCue PA, Sang N, Ji JY, et al: Repression of endometrial
tumor growth by targeting SREBP1 and lipogenesis. Cell cycle.
11:2348–2358. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jackstadt R, Röh S, Neumann J, Jung P,
Hoffmann R, Horst D, Berens C, Bornkamm GW, Kirchner T, Menssen A
and Hermeking H: AP4 is a mediator of epithelial-mesenchymal
transition and metastasis in colorectal cancer. J Exp Med.
210:1331–1350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kurita K, Maeda M, Mansour MA, Kokuryo T,
Uehara K, Yokoyama Y, Nagino M, Hamaguchi M and Senga T: TRIP13 is
expressed in colorectal cancer and promotes cancer cell invasion.
Oncol Lett. 12:5240–5246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Long J, Xie Y, Yin J, Lu W and Fang S:
SphK1 promotes tumor cell migration and invasion in colorectal
cancer. Tumour Biol. 37:6831–6836. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boudjadi S, Carrier JC, Groulx JF and
Beaulieu JF: Integrin α1β1 expression is controlled by c-MYC in
colorectal cancer cells. Oncogene. 35:1671–1678. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang L, Liu X, Zuo Z, Hao C and Ma Y:
Sphingosine kinase 2 promotes colorectal cancer cell proliferation
and invasion by enhancing MYC expression. Tumour Biol.
37:8455–8460. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Jiang Y, Hou Y, Hu Y, Cao X, Tao Y,
Xu C, Liu S, Wang S, Wang L, et al: The IκB family member Bcl-3
stabilizes c-Myc in colorectal cancer. J Mol Cell Biol. 5:280–282.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu Y, Chen K and Liu X, Huang L, Zhao D,
Li L, Gao M, Pei D, Wang C and Liu X: Srebp-1 Interacts with c-Myc
to enhance somatic cell reprogramming. Stem cells. 34:83–92. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smith AP, Verrecchia A, Fagà G, Doni M,
Perna D, Martinato F, Guccione E and Amati B: A positive role for
Myc in TGFbeta-induced Snail transcription and
epithelial-to-mesenchymal transition. Oncogene. 28:422–430. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cho KB, Cho MK, Lee WY and Kang KW:
Overexpression of c-myc induces epithelial mesenchymal transition
in mammary epithelial cells. Cancer Lett. 293:230–239. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yao C, Su L, Shan J, Zhu C, Liu L, Liu C,
Xu Y, Yang Z, Bian X, Shao J, et al: IGF/STAT3/NANOG/slug signaling
axis simultaneously controls epithelial-mesenchymal transition and
stemness maintenance in colorectal cancer. Stem cells. 34:820–831.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Beloribi-Djefaflia S, Vasseur S and
Guillaumond F: Lipid metabolic reprogramming in cancer cells.
Oncogenesis. 5:e1892016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun Y, He W, Luo M, Zhou Y, Chang G, Ren
W, Wu K, Li X, Shen J, Zhao X and Hu Y: SREBP1 regulates
tumorigenesis and prognosis of pancreatic cancer through targeting
lipid metabolism. Tumour Biol. 36:4133–4141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chuan YC, Iglesias-Gato D, Fernandez-Perez
L, Cedazo-Minguez A, Pang ST, Norstedt G, Pousette A and
Flores-Morales A: Ezrin mediates c-Myc actions in prostate cancer
cell invasion. Oncogene. 29:1531–1542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu W, Cai MY, Tong ZT, Dong SS, Mai SJ,
Liao YJ, Bian XW, Lin MC, Kung HF, Zeng YX, et al: Overexpression
of EIF5A2 promotes colorectal carcinoma cell aggressiveness by
upregulating MTA1 through C-myc to induce
epithelial-mesenchymaltransition. Gut. 61:562–575. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mansour MA, Hyodo T, Akter KA, Kokuryo T,
Uehara K, Nagino M and Senga T: SATB1 and SATB2 play opposing roles
in c-Myc expression and progression of colorectal cancer.
Oncotarget. 7:4993–5006. 2016. View Article : Google Scholar : PubMed/NCBI
|
